| Code | 8384B | ||||||||||
| MA number | 44/0058/16-S | ||||||||||
| Product Form: | con inf 1x20 ml/500 mg (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 25.02.2016 |
| SPC: |
SPC_Pemetrexed STADA 25 mg_ml koncentrát na infúzny roztok_05.2025.pdf
|
| PIL: |
PIL_Pemetrexed STADA 25 mg_ml koncentrát na infúzny roztok_05.2025.pdf
|
| Safety feature | Yes |
| Data update: | 11.05.2023 |
